Utama › Hipersomnia Idiopatik › Ohio
Kajian klinikal Hipersomnia Idiopatik di Ohio
7 kajian untuk Hipersomnia Idiopatik sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Takeda Site 2, Cincinnati
- Takeda Site 4, Cincinnati
Mengambil pesertaFasa 2/3
Umur 18 hingga 71 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07646678A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Neuroscience Research Center, LLC, Canton
- Intrepid Research, Cincinnati
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07500090A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Intrepid Research, Cincinnati
- Ohio Sleep Medicine and Neuroscience Institute, Dublin
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- dan 1 lagi
Mengambil pesertaFasa 2/3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06767683A Study of TAK-360 in Adults With Idiopathic Hypersomnia
- Takeda Site 12, Cincinnati
- Takeda Site 17, Cincinnati
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06812078A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Cleveland, OH, Cleveland
- Dublin, Ohio, Dublin
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT06752668A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT07096674Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.